chrX-48479062-C-G
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_012280.4(FTSJ1):c.307C>G(p.Gln103Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00116 in 1,205,974 control chromosomes in the GnomAD database, including 12 homozygotes. There are 381 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_012280.4 missense
Scores
Clinical Significance
Conservation
Publications
- intellectual disability, X-linked 9Inheritance: XL Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
 - X-linked complex neurodevelopmental disorderInheritance: XL Classification: DEFINITIVE Submitted by: ClinGen
 - non-syndromic X-linked intellectual disabilityInheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
 
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -20 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt | 
|---|---|---|---|---|---|---|---|---|
| FTSJ1 | NM_012280.4  | c.307C>G | p.Gln103Glu | missense_variant | Exon 5 of 13 | ENST00000348411.3 | NP_036412.1 | 
Ensembl
Frequencies
GnomAD3 genomes   AF:  0.00579  AC: 652AN: 112557Hom.:  6  Cov.: 24 show subpopulations 
GnomAD2 exomes  AF:  0.00166  AC: 304AN: 183269 AF XY:  0.000945   show subpopulations 
GnomAD4 exome  AF:  0.000686  AC: 750AN: 1093363Hom.:  6  Cov.: 29 AF XY:  0.000596  AC XY: 214AN XY: 359023 show subpopulations 
Age Distribution
GnomAD4 genome   AF:  0.00581  AC: 654AN: 112611Hom.:  6  Cov.: 24 AF XY:  0.00480  AC XY: 167AN XY: 34783 show subpopulations 
Age Distribution
ClinVar
Submissions by phenotype
not provided    Benign:4 
- -
- -
- -
- -
not specified    Benign:1 
- -
Inborn genetic diseases    Benign:1 
This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Computational scores
Source: 
Splicing
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at